1. P663 Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn's disease patients: results from the AURORA Study including ANZIBDC Cohort. (30th January 2023) Authors: An, Y K; Lindsay, N; Allan, N; Khoo, E; Fernandes, R; Amiss, A; Pham, H; Wong, K F; Ooi, S Y; Thin, L; Lightowler, D; Connor, S J; Williams, A J; De Cruz, P; Li Wai Suen, C; Kariyawasam, V; Mitrev, N; Ghaly, S; Andrews, J M; Christensen, B Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗